[
  {
    "ts": null,
    "headline": "Cardinal Health Inc. stock outperforms competitors on strong trading day",
    "summary": "Cardinal Health Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=2294c69b8eb67054bd434a22680693477db0b7acc399ca2eaf48137f9973fde6",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742230560,
      "headline": "Cardinal Health Inc. stock outperforms competitors on strong trading day",
      "id": 133228259,
      "image": "",
      "related": "CAH",
      "source": "MarketWatch",
      "summary": "Cardinal Health Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=2294c69b8eb67054bd434a22680693477db0b7acc399ca2eaf48137f9973fde6"
    }
  },
  {
    "ts": null,
    "headline": "Lifeward Stock Falls Despite FDA Clearance of ReWalk 7 Exoskeleton",
    "summary": "LFWD secures FDA clearance for its ReWalk 7 Exoskeleton, introducing enhanced features to empower individuals with spinal cord injury and expand mobility options.",
    "url": "https://finnhub.io/api/news?id=b20010bab5b3b16b8ad4d8d74f93b6f338f2acaef335ffe38b9d206e3d4901f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742229240,
      "headline": "Lifeward Stock Falls Despite FDA Clearance of ReWalk 7 Exoskeleton",
      "id": 133326613,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "LFWD secures FDA clearance for its ReWalk 7 Exoskeleton, introducing enhanced features to empower individuals with spinal cord injury and expand mobility options.",
      "url": "https://finnhub.io/api/news?id=b20010bab5b3b16b8ad4d8d74f93b6f338f2acaef335ffe38b9d206e3d4901f9"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories Gains 12.7% in a Year: What's Driving the Stock?",
    "summary": "ABT's shares rise on the back of its diversified business portfolio. However, the unfavorable macroeconomic scenario is concerning.",
    "url": "https://finnhub.io/api/news?id=ffce312c973e80ffe728bcc5d0c3daddace593f6c0c1df08d5b5d3b177255aa7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1742220900,
      "headline": "Abbott Laboratories Gains 12.7% in a Year: What's Driving the Stock?",
      "id": 133324825,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "ABT's shares rise on the back of its diversified business portfolio. However, the unfavorable macroeconomic scenario is concerning.",
      "url": "https://finnhub.io/api/news?id=ffce312c973e80ffe728bcc5d0c3daddace593f6c0c1df08d5b5d3b177255aa7"
    }
  }
]